Roche’s Analyst Event at ASCO 2018
Highlights in cancer immunotherapy
Biomarkers in the era of cancer immunotherapy
Highlights late stage portfolio outside cancer immunotherapy
Oncology strategy and impact on patients
Alan Sandler, M.D., a.i. Global Head Oncology, Global Head Lung Cancer Franchise
Priti S. Hegde, Ph.D., Oncology Biomarker Development
Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development
Daniel O’Day, CEO Roche Pharmaceuticals

Please register to access the replay*

*Privacy notice

Video Webcast Replay

Roche has hosted an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).

Past IR Events
View more Events


Related links